Publication | Open Access

In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift

Cell-based Drug DeliveryCell TherapyMedicineT-regulatory CellImmunologyT-cell ActivationT Cell ImmunityAnti-cd3-conjugated Lipid NanoparticlesCell BiologySitu T-cell Transfection